Furthermore, in RUNX2 knockdown cells, the ccRCC progression was enhanced by SCD1 overexpression and the Wnt/β‐catenin signaling pathway was activated as SCD1 was overexpressed. The gene discussed is RUNX2; the disease is nonpapillary renal cell carcinoma.